Eli Lilly beats fourth-quarter earnings forecast, raises 2023 outlook, on Trulicity’s strength
"Over the course of this critical year, we expect to launch up to four new drugs for challenging diseases, while ...
"Over the course of this critical year, we expect to launch up to four new drugs for challenging diseases, while ...